Ikena Oncology Announces $40 Million Underwriting Offer – Ikena…
BOSTON, May 15, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. IKNA “Ikena” (“Company”)), a specialty oncology company pioneering patient-centric cancer care, today announced pricing for
Home » Oncology
BOSTON, May 15, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. IKNA “Ikena” (“Company”)), a specialty oncology company pioneering patient-centric cancer care, today announced pricing for
SAN FRANCISCO, May 8, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. ((“Olema” or “Olema Oncology, NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development
EAGAN, Minn., May 02, 2023 (GLOBE NEWSWIRE) — Predictive Oncology Inc. POAI, a science-driven company that leverages its proprietary artificial intelligence and machine learning, extensive
MONT-SAINT-GUIBERT, Belgium, March 24, 2023 (GLOBE NEWSWIRE) – Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the “Company”), a biotechnology company focused on innovative technologies for Chimeric Antigen
– Presentations highlighting preclinical data supporting the combination of FTIs with KRASG12C Inhibitors and Tyrosine Kinase Inhibitors – SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE)
Corbus Pharmaceuticals Holdings Inc CRBP occurred exclusive license agreement with CSPC Megalith Biopharmaceutical Co Ltda subsidiary of CSPC Pharmaceutical Group Limitedfor the development and commercialization
NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc.a clinical-stage biopharmaceutical company pioneering the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural
BOSTON, Jan. 3, 2023 (GLOBE NEWSWIRE) — AVEO Oncology (“AVEO”) AVEO, a commercial-stage oncology biopharmaceutical company dedicated to providing medicines that help cancer patients live
SAN FRANCISCO, Jan. 3, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. ((“Olema”, “Olema Oncology”, NASDAQ:OLMA) announced today that Sean Bohen, MD, President and Chief Executive
Celyades Oncology CYAD offers an update on its Celyad 2.0 business strategy, which has been adopted and implemented in recent months. The company has
A serious injury can change your financial situation within days. Medical bills may start arriving while you are still receiving treatment, and time away from
A dog bite can turn an ordinary afternoon into an emergency within seconds. For parents, the first concern is usually the injury itself. You need
Filing an insurance claim can seem straightforward. You report a loss, provide documentation, and wait for the insurer to evaluate what happened. In practice, claims